Ranolazine Tablet, Extended Release
Product Images NDC 63304-017

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 63304-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-ranolazine-1000mg-label (Spl Ranolazine 1000mg Label)

This is a drug label for Ranolazine Extended-Release tablets with a dosage strength of 1000 mg. It should be taken by swallowing the tablets whole, without crushing or breaking them. The drug is distributed by Sun Pharmaceuticals Industries, Inc. and the label includes a product code and contact information for the manufacturer.*

FDA Label Image

Spl-ranolazine-500mg-label (Spl Ranolazine 500mg Label)

This is a medication label for Ranolazine Extended-Release Tablets in a 500mg strength. It should be swallowed whole and not crushed, broken or chewed. The label indicates that it is a prescription drug and comes in a bottle of 60 tablets. However, there seems to be some text missing or not readable in the middle of the label.*

FDA Label Image

Spl-ranolazine-er-tablets-structure (Spl Ranolazine Er Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.